Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
Therapeutic cancer vaccines: using unique antigens
Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]
High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
Autologous dendritic cell vaccines for non-small-cell lung cancer
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients
Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy
Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer
Dendritic cells generated in the presence of interferon-alpha stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells
Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part I: Convective hyperthermia
Selective functional deficit in dendritic cell–T cell interaction is a crucial mechanism in chronic hepatitis B virus infection
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
Dendritic cell vaccination in medullary thyroid carcinoma